Product Description: Keap1-Nrf2-IN-20 (Compound ZC9) is an inhibitor for Keap-Nrf2 pathway with KD2 of 51 nM. Keap1-Nrf2-IN-20 exhibits good cell permeability, cell activity, and metabolic stability (serum t1/2 > 24 h)[1].
Applications: COVID-19-immunoregulation
Formula: C42H67N11O19
References: [1]Zou J, et al., Cyclic Peptide Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Design, Synthesis, and In Vivo Treatment of Acute Lung Injury. J Med Chem. 2024 Mar 28;67(6):4889-4903.
Molecular Weight: 1030.04
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Keap1-Nrf2